The hospital has seen increasing activity in this area, offering new therapeutic opportunities and improving survival expectations and quality of life for numerous patients. CAR-T therapy, which uses genetically modified T-cells from the patient's own body to attack cancer cells, has been administered to patients with lymphomas and myelomas who did not respond to conventional treatments.
Since its accreditation in 2019 by the Ministry of Health, the Doctor Negrín Hospital has treated this hundred patients, reaffirming its role as a reference center in the Canary Islands for complex hematological pathologies. This achievement is the result of coordinated work by multidisciplinary teams, including Hematology, Hospital Pharmacy, Neurology, Intensive Medicine, and specialized Nursing.
Recently, the Hematology department has incorporated the treatment of myelomas in the second line. The hospital is also a reference center for allogeneic hematopoietic stem cell transplantation. The intense research and training activities of the diagnostic laboratory contribute to the continuous improvement of patient care.
A multidisciplinary CAR-T committee meets periodically with hematologists and oncologists from across the Canary Islands autonomous community to present new cases and update data on treated patients.
